CA Patent

CA3262795A1 — METHOD FOR IDENTIFYING SPECIFIC ALTERATIONS IN SUBJECTS WITH DEFINED DISEASES BY ANALYZING OCULOMOTOR PATTERNS DURING THE USE OF SPECIFIC VISUAL STIMULI, A SPECIFIC MEDICINE OR TREATMENT THAT IMPROVES VISUAL PROCESSING, COGNITIVE PERFORMANCE AND ASSOCIATED BRAIN ACTIVITIES

Assigned to Viewmind Inc · Expires 2024-02-01 · 2y expired

What this patent protects

Patent listed against fingolimod-hydrochloride.

Drugs covered by this patent

fingolimod-hydrochloride (FINGOLIMOD HYDROCHLORIDE)

Patent Metadata

Patent number: CA3262795A1
Jurisdiction: CA
Classification: —
Expires: 2024-02-01
Drug substance claim: No
Drug product claim: No
Assignee: Viewmind Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.